NCBiotech News

Children aged 2 and older will soon be able to get tested at home using LabCorp’s rapid coronavirus test kit.

Durham's Tellus Therapeutics is pushing ahead with developing its neonatal brain injury treatment after landing crucial seed funding this week.

The North Carolina Biotechnology Center awarded 48 grants and loans totaling nearly $1.8 million to universities, bioscience companies and other entities in the third quarter of its fiscal year.

Researchers at NC State and UNC Greensboro, with help from an NCBiotech grant, discover a new species of bacteria that is highly attractive to pregnant sand flies that could lead to safe baits or traps to reduce sand fly populations.

Elizabeth City agricultural startup IngateyGen, which has received funding support from NCBiotech, has now landed an SBIR grant worth nearly $1 million for its work using CRISPR gene editing to remove allergens from peanuts.

Each year, 160 students earn the BioWork certification from Johnston Community College, paving the way to fulfilling careers in biopharmaceutical manufacturing.

A trio of Triangle scientists is launching Isolere Bio, bootstrapped with a $250K NCBiotech loan that led to $7 million in seed funding attracted by the technology they believe can allow gene therapy companies to vastly increase the number of doses they can produce.

Isosceles Pharmaceuticals Inc., a Wilmington company developing synthetic cannabidiol to treat pain and inflammatory diseases, has named William Humphries as its CEO.

High Point University plans to invest $150 million to create a School of Dental Medicine and Oral Health, which would be the only dental school at a private university in North Carolina

Tergus Pharma has officially moved into manufacturing as it gets set to open its new headquarters in Durham. And it promises more jobs are on the horizon.

Four lucky Durham Technical Community College students will soon pioneer a bold new apprenticeship program with Durham-based KBI Biopharma designed to groom more workers for pharmaceutical manufacturing.

On Friday, May 7, 2021, Alamance Community College will observe the groundbreaking of its groundbreaking $17.6 million Biotechnology Center of Excellence.

Raleigh-based Aceragen, which focuses on treatments for rare illnesses, has acquired an investigational Farber Disease therapy – ACG-801 – from RTP neighbor Enzyvant

UNC-affiliated startup RainBio is parlaying support from NCBiotech to develop a novel gene therapy for corneal blindness, giving patients a chance not only for longer lives, but better ones.

Novozymes, with U.S. headquarters in North Carolina, is leaning into a strategic alliance with Univar Solutions to expand its reach across multiple markets in North America.